- Release Date: 21/09/23 08:58
- Summary: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
- Price Sensitive: Yes
- Download Document 322.24KB
- Forums
- ASX - By Stock
- Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
-
- There are more pages in this discussion • 218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.71 |
Change
-0.035(2.01%) |
Mkt cap ! $291.2M |
Open | High | Low | Value | Volume |
$1.78 | $1.78 | $1.71 | $38.86K | 22.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 916 | $1.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.72 | 2009 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 916 | 1.710 |
2 | 6800 | 1.705 |
7 | 12385 | 1.700 |
1 | 1000 | 1.695 |
1 | 1000 | 1.690 |
Price($) | Vol. | No. |
---|---|---|
1.735 | 2971 | 2 |
1.740 | 2025 | 3 |
1.745 | 5575 | 1 |
1.750 | 609 | 1 |
1.760 | 421 | 1 |
Last trade - 10.42am 03/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online